CureHIV Seeks Funding for LiSAVIOR from Bill and Melinda Gates' Grand Challenges to Cure HIV
Dr. Roger Kenneth Hershline PhD MD, Global Humanceuticals, Inc and CureHIV apply to Bill and Melinda Gates' Grand Challenges in Global Health to fund the new HIV non-traditional drug LiSAVIOR. Current drug and vaccination treatments do not treat the growth of HIV in the gastrointestinal tract. - April 02, 2008
Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New Powerful Class of HIV Viral Drug
Dr. Roger Kenneth Hershline PhD MD, Chairman and Founder of CureHIV.us, agreed to provide samples of Global Humanceuticals, Inc’s NIAID#11039, a new powerful class of anti-HIV drug to clinical researchers. The drug is able de-activates the virus even if diluted nearly a billion times. - September 09, 2007
CureHIV Predicts Number of HIV Cases to Skyrocket
Dr. Hershline states that, baring a new preventative, CureHIV now predicts over 700 million worldwide HIV infected humans by the New Year 2018, as this global pandemic emerges. - July 15, 2007